Explanipedia

ASSOCIATION BETWEEN TYPE AND LOCATION OF GERMLINE BRCA1/2 PATHOGENIC OR LIKELY PATHOGENIC VARIANTS WITH PHENOTYPE AND PROGNOSIS IN YOUNG PATIENTS WITH BREAST CANCER: RESULTS FROM AN INTERNATIONAL COHORT STUDY Open

Eva Blondeaux, Elena Tenedini, Rossella Graffeo, L Livraghi, Judith Balmañà , et al. · 2025

ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic Open

Sasha Douglas, Samantha M. Thomas, Astrid Botty van den Bruele, Ton Wang, Kendra Modell Parrish , et al. · 2025

Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery Open

Sasha Douglas, Samantha M. Thomas, Akiko Chiba, Maggie L. DiNome, Gayle DiLalla , et al. · 2025

Background De-escalation of axillary surgery for hormone receptor-positive breast cancer has gained traction, but guidelines for axillary management after neoadjuvant endocrine therapy (NET) remain ill-defined. Methods Female patients age …

Germline genetic mutations in a multi-center cohort of 248 phyllodes tumors Open

Laura H. Rosenberger, Samantha M. Thomas, Tina J. Hieken, Kristalyn K. Gallagher, Philip M. Spanheimer , et al. · 2025

Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants’ and Program Directors’ Preferences Regarding In-Person Versus Virtual Interviews Open

Jennifer K. Plichta, Richard J. Bleicher, Judy C. Boughey, Julie A. Margenthaler, Holly Mason , et al. · 2025

Evaluating axillary lymph node metastasis risks in breast cancer patients via Semi-ALNP: a multicenter study Open

Limeng Qu, Jinfeng Zhu, Xilong Mei, Zixi Yi, Na Luo , et al. · 2025

<i>ERBB2</i>-Low Expression by Race and Ethnicity Among Patients With Triple-Negative Breast Cancer Open

Astrid Botty van den Bruele, Kerri‐Anne Crowell, Samantha M. Thomas, Hannah E. Woriax, Kendra Modell Parrish , et al. · 2025

Importance Racial and ethnic disparities in pathologic complete response (pCR) and overall survival (OS) have been reported in patients with triple-negative breast cancer (TNBC). In addition to socioeconomic factors and access to care, dif…

Trends in Axillary Lymph Node Dissection After Mastectomy Among Patients With Limited Nodal Burden Open

Ton Wang, Tyler Jones, Samantha M. Thomas, Astrid Botty van den Bruele, Laura H. Rosenberger , et al. · 2025

Importance Current practices in axillary treatment for patients with breast cancer who receive a mastectomy for node-positive disease are unknown. For patients who receive postmastectomy radiotherapy (PMRT), the addition of axillary lymph …

P264: Survival from ER-positive breast cancer in women who carry a BRCA1 mutation Open

Steven A. Narod, Jan Lubiński, Natalie Wong, Jitka Soukupová, Rinat Bernstein‐Molho , et al. · 2025

ASO Visual Abstract: Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia Open

Jessica Limberg, Samantha Thomas, Juliet C Dalton, Koumani W Ntowe, Amanda L. Nash , et al. · 2024

Clinical genetics in breast cancer Open

Koumani W Ntowe, Michael S. Lee, Jennifer K. Plichta · 2024

As genetic testing becomes increasingly more accessible and more applicable with a broader range of clinical implications, it may also become more challenging for breast cancer providers to remain up‐to‐date. This review outlines some of t…

Digital Health Platforms for Breast Cancer Care: A Scoping Review Open

Elayna Kirsch, Sameer Kunte, Kevin A. Wu, Samantha Kaplan, E. Shelley Hwang , et al. · 2024

Breast cancer is a significant global health concern affecting millions of women each year. Digital health platforms are an easily accessible intervention that can improve patient care, though their efficacy in breast cancer care is unknow…

Survival among patients with untreated metastatic breast cancer: “What if I do nothing?” Open

Jennifer K. Plichta, Samantha M. Thomas, Xuanji Wang, Susan G. R. McDuff, Gretchen Kimmick , et al. · 2024

Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer? Open

Sydney M. Record, Samantha M. Thomas, William M. Tian, Astrid Botty van den Bruele, Akiko Chiba , et al. · 2024

De-Escalated Neoadjuvant Weekly Nab-Paclitaxel with Trastuzumab and Pertuzumab in HER2-Positive Early Breast Cancer (HELEN-006): A Randomized, Phase 3 Trial Open

Xiuchun Chen, Dechuang Jiao, Jianghua Qiao, Chengzheng Wang, Xianfu Sun , et al. · 2024

Implementation of a novel peer review academy by Surgery and the Association of Women Surgeons Open

M. Libby Weaver, Laura M. Drudi, Alexandra M. Adams, Isabella Faria, Hope Feldman , et al. · 2023

BRCA1/2 mutation carriers & risk reducing mastectomy: Who undergoes surgery and potential benefits Open

Sydney M. Record, Samantha M. Thomas, Koumani W Ntowe, Akiko Chiba, Jennifer K. Plichta · 2023

Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy: A National Cancer Database Analysis Open

Huiyue Li, Jennifer K. Plichta, Kan Li, Yizi Jin, Samantha M. Thomas , et al. · 2023

Purpose To investigate potential differences in pathological complete response (pCR) rates and overall survival (OS) between HER2-low and HER2-zero patients with early-stage hormone receptor (HR)-positive and triple-negative breast cancer …

NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023 Open

Therese B. Bevers, Bethany L. Niell, Jennifer L. Baker, Debbie L. Bennett, Ermelinda Bonaccio , et al. · 2023

The NCCN Guidelines for Breast Cancer Screening and Diagnosis provide health care providers with a practical, consistent framework for screening and evaluating a spectrum of clinical presentations and breast lesions. The NCCN Breast Cancer…

Prognostic Tools for Older Women with Breast Cancer: A Systematic Review Open

Sydney M. Record, Tori Chanenchuk, Kendra Modell Parrish, Samantha Kaplan, Gretchen Kimmick , et al. · 2023

Background: Breast cancer is the most common cancer in women, and older patients comprise an increasing proportion of patients with this disease. The older breast cancer population is heterogenous with unique factors affecting clinical dec…

ASO Visual Abstract: Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer—Comparison of Approaches Open

Krislyn N. Miller, Samantha M. Thomas, Sydney M. Record, Laura H. Rosenberger, Maggie L. DiNome , et al. · 2023

Neoadjuvant Chemotherapy and Endocrine Therapy for Older Patients with Estrogen Receptor Positive Breast Cancer: Comparison of Approaches Open

Krislyn N. Miller, Samantha M. Thomas, Sydney M. Record, Laura H. Rosenberger, Maggie L. DiNome , et al. · 2023

Breast Cancer Risk Assessment and Screening Practices Reported Via an Online Survey Open

Sydney M. Record, Samantha M. Thomas, Tori Chanenchuk, Jay A. Baker, Lars J. Grimm , et al. · 2023

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer Open

Jennifer K. Plichta, Samantha M. Thomas, Daniel F. Hayes, Mariana Chávez‐MacGregor, Kimberly H. Allison , et al. · 2023

PURPOSE Given the heterogeneity and improvement in outcomes for metastatic breast cancer (MBC), we developed a staging system that refines prognostic estimates for patients with metastatic cancer at the time of initial diagnosis, de novo M…

Issue Information – Editorial Board Open

C Bicket, Chad M. Brummett, Edward R. Mariano, Thomas Lam, Ting Xia , et al. · 2023

the opioid epidemic: a simple solution or short-lived sensation?M.

De-Escalation of Axillary Surgery for Older Patients with Breast Cancer: Supporting Data Continue to Accumulate Open

Sydney M. Record, Jennifer K. Plichta · 2023

Table of Contents (4 pgs) Open

Herbert Chen, Elizabeth Shaughnessy, Hannah N. Marmor, Lisa K. Cannada, Anees B. Chagpar , et al. · 2022

Implications of missing data on reported breast cancer mortality Open

Jennifer K. Plichta, Christel Rushing, H Lewis, Marguerite Rooney, Dan G. Blazer , et al. · 2022

The art of peer review: Guidelines to become a credible and constructive peer reviewer Open

M. Libby Weaver, Rachael Sundland, Alexandra M. Adams, Isabella Faria, Hope Feldman , et al. · 2022

The role of tumor phenotype in the surgical treatment of early-stage breast cancer Open

Marguerite Rooney, Samantha M. Thomas, Mahsa Taskindoust, Rachel A. Greenup, Laura H. Rosenberger , et al. · 2022

Jennifer K. Plichta YOU? Author Swipe